Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Citius Pharmaceuticals, Inc. (CTXR) had Income from Continuous Operations of $-28.11M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$1.67M |
|
$-21.23M |
|
$0.33M |
|
$1.34M |
|
$33.86M |
|
$-32.19M |
|
$3.85M |
|
$-28.34M |
|
$-28.34M |
|
$-28.11M |
|
|
Income from Continuous Operations |
$-28.11M |
$-28.11M |
|
$-28.11M |
|
$-32.19M |
|
$-30.43M |
|
22.38M |
|
22.38M |
|
$-0.95 |
|
$-0.95 |
|
| Balance Sheet Financials | |
$31.69M |
|
-- |
|
$100.85M |
|
$132.54M |
|
$55.02M |
|
-- |
|
$8.44M |
|
$63.46M |
|
$69.08M |
|
$59.74M |
|
$69.08M |
|
22.38M |
|
| Cash Flow Statement Financials | |
$-14.31M |
|
$-5.00M |
|
$19.65M |
|
$4.25M |
|
$4.59M |
|
$0.34M |
|
$8.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.58 |
|
-- |
|
-- |
|
-- |
|
-- |
|
80.27% |
|
-1930.96% |
|
-1930.96% |
|
-- |
|
-1699.81% |
|
-1273.39% |
|
$-14.31M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
1.55 |
|
58.25 |
|
-40.69% |
|
-47.06% |
|
-21.21% |
|
-40.69% |
|
$3.09 |
|
$-0.64 |
|
$-0.64 |
|